---
schema_version: "secwatch.filing_event.v1"
accession: "0000724004-25-000012"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:05:25.191872+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs 2Q26 revenue up 5%, net income down 27.8% on tariffs and China headwinds

## Summary
- Total revenues $60.7M, +5.0% YoY; core organic growth 3.7%.
- Net income $2.5M ($0.45 diluted EPS), down 27.8% from 2Q25.
- Non-GAAP AOI excluding unusual items $15.2M, +6.1%; margin 25.1% vs 24.8%.
- Clinical Genomics core organic -3.6%: China -58%; outside China +16.2%.
- Annualized cost reductions of $3.2M; net savings $2.3M after reinvestment. Tariffs 70 bps of revenue.

## SEC filing metadata
- accession: 0000724004-25-000012
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/0000724004-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/mlab20251106_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000724004-25-000012
- JSON: https://secwatch.observer/filing/0000724004-25-000012.json
- Plain text: https://secwatch.observer/filing/0000724004-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.